Overall, the weight-loss fields deal volume in 2025 H1 has been record-high , driven by the blockbuster success of current GLP-1 drugs
Some of the Key Market Players: Novo Nordisk A/S Eli Lilly and Company Sanofi AstraZeneca Jiangsu Hansoh Pharmaceutical Group Co., Ltd
Glucagon-like peptide agonists for weight management in antipsychotic-induced weight gain: a systematic review and meta-analysis[J]
Regular Facial Massage : Increases circulation and may help maintain facial muscle tone
Free Case Evaluation No commitment
Unlike programs that focus on a single medication or method, our curriculum encompasses a wide range of evidence-based protocols, including FDA-approved pharmaceutical treatments, hormonal therapies, and adjunctive procedures